双功能二亚乙基三胺五乙酸系列配体作为磁共振成像造影剂的合成研究进展

二亚乙基三胺五乙酸(DTPA)及其衍生物具有优良的配位性能,在化学及生物医学领域有广泛的应用,尤其是作为磁共振成像造影剂.双功能DTPA类配体对于研发DTPA类磁共振成像造影剂具有重要的作用,制备符合不同要求的该类配体具有相当的难度.着重介绍双功能DTPA类配体的各种合成方法,并对不同的方法和路线优缺点进行比较.     

Synthesis and Characterization of 2-DecyI-DTPA and Its Gd （Ⅲ） Chelate

The present paper covers the synthesis and the characterization of ligand 2-decyl-3, 6, 9-tris (car-boxymethyl)-3,6,9-triazaundecan-1,11-dioic acid, HsL, and its Gd (Ⅲ) chelate. The protonation constantsfor HsL(IgKi^H= 10. 90, 8.50, 4.55, 2.92., 2.20) and the stability constant for GdL^2- (lgKGdL^2- = 2.2.80)were determined by means of potentiometric titration. They are similar to the corresponding values of DTPAand Gd-DTPA, respectively. The results obtained show that the basicity of the ligand and the stability con-stant of its Gd (Ⅲ) chelate are not obviously altered after the introduction of a linear chain decyl group intothe terminal acetic acid residue of DTPA. The Gd(Ⅲ) chelate may be a potential contrast agent with liver-specificity for magnetic resonance imaging(MRI).     

Syntheses and Crystal Structures of Lanthanide Complexes of New 15-Membered Macrocyclic Ligands with Three Pendant Acetato Groups

Two new 15-memhored fimctionalized macrocycles, dioxo-polyazacydoalkanes with three pendant acetato groups, have been synthesized by the condensation reaction of DTPA dianhy-dride (DTPA = diethylenetrlamlnepentaacetic acid ) with 1,2-di-amlnopropane, ( 15-DTPA-1, 2-pn), or 1, 2-diaminocydohex-ane, (15-DTPA-1,2-cy). Their lanthanide complexes [ Ln ( 15-DTPA-1,2-pn)(H2O)]2[Ln= Eu (1), Gd (2)] and [Ln(15-DTPA-1,2-cy)(H2O)]2[Ln= Eu (3), Gd (4)] were also pre-pared. Single crystal X-ray diffraction analyses of complexes 2 and 4 show that they have dimeric structures in solid state;each metal ion is nine-coordinated in a distorted tricapped-trig-onal prism. In complex 4, the coexistence of two diastereoiso-meric molecules in the crystal lattice was observed.     

荧光/MRI双模态靶向成像诊疗试剂的制备

在聚乙二醇二胺(NH_2-PEG-NH_2)修饰的石墨烯量子点(GODs)表面以酰胺键偶联二乙基三胺五乙酸(DTPA)分子,之后将Gd~(3+)离子与其进行配合,得到了GODs-Gd(DTPA)复合纳米粒子,然后再通过酰胺键在GODs-Gd(DTPA)的表面修饰叶酸(FA)靶分子,最后进一步将阿霉素(DOX)通过π-π堆垛吸附在造影剂的表面,制备了FA/GODs-Gd(DTPA)/DOX荧光/MRI双模态靶向肺癌细胞成像诊疗试剂,通过透射电子显微镜、紫外可见吸收光谱、荧光光谱和激光共聚焦扫描显微镜等手段表征了其形貌、发光性能和靶向成像性能。MRI、激光共聚焦扫描显微镜和MTT等结果表明,相对于正常的HLF细胞,所制备的FA/GODs-Gd(DTPA)/DOX纳米粒子能够靶向检测FA受体高表达的肺癌H460细胞,并具有明显的抗肿瘤活性。     

Esterification of levulinic acid to n-butyl levulinate over heteropolyacid supported on acid-treated clay

Levulinic acid has been identified as a promising green, biomass-derived platform chemical. n-Butyl levulinate is used as an important intermediate having diverse applications. The present work focuses on the synthesis of n-butyl levulinate by esterification of levulinic acid with n-butanol using heteropolyacid (HPA) supported on acid-treated clay montmorillonite (K10). 20% (w/w) dodecatungestophosphoric acid (DTPA) supported on K10 was found to be the most efficient catalyst with 97% levulinic acid conversion and 100% selectivity towards n-butyl levulinate. Effects of various process parameters were studied to examine the efficacy of 20% (w/w) DTPA/K10 for optimization of the activity.     

计算机模拟研究Pu~(4+)在人体血浆中的分布

建立了由多种金属离子和小分子配体组成的多相人体血浆热力学平衡模型。模拟研究了Pu4+在血浆的形态分布及二乙三胺五乙酸(DTPA)和CO32-、Citrate3-浓度对细胞液中Pu4+形态分布的影响。血浆中的低浓度Pu(Ⅳ)易以Pu(OH)4(aq)的形态蓄积在肝脏中,钚浓度升高则形成沉淀Pu(OH)4(s)难以排出。在[DTPA]=2.5×10-5mol·L-1时,血浆中水溶性小分子[Pu(OH)DTPA]2-含量达到最高并保持稳定。酸性条件下随着[Citrate3-]的升高,血浆中Pu4+与Citrate3-结合形成可溶性的[PuCitrate2]2-和[PuCitrate]+离子化合物。[DTPA]4.6×10-5mol·L-1时,血浆中的DTPA以与Ca2+、Mg2+结合的[CaHDTPA]2-、[Ca2DTPA]-、[CaDTPA]3-、[MgHDTPA]2-、[MgDTPA]3-小分子结合态为主。     

稀土胺羧酸配合物的研究 I. {[MnGd(DTPA)(H2O)5]2·H2O}n配合物的合成和晶体结构

本文首次合成了{MnLn(DTPA)(H2O)5]·H2O}n异核链式配合物(Ln=Gd, Er, Y)单晶,测定了{[MnGd(DTPA)(H2O)5]2·H2O]n的单晶结构。     

稀土胺羧酸配合物的研究——Ⅰ.{[MnGd(DTPA)(H_2O)_5]_2·H_2O}_n配合物的合成和晶体结构

在水溶液中合成了二乙三胺五乙酸锰钆铒和钇的棱状晶体,元素分析结果表明可用{MnLn(DTPA)}_2·11H_2O表示(Ln为Gd,Er,Y;DTPA为二乙三胺五乙酸根).用X射线衍射方法测定了{MnGd(DTPA)}2·11H_2O的单晶结构,其结构式为{[MnGd(DTPA)(H_2O)_σ]_2·H_2O}n,属三斜晶系,空间群为PI,每一晶胞中有1个配合单元,形成一维链式配合物.晶胞参数如下:a=1.5896(3),b=0.8897(1),c=0.8146(1)nm;a=77.04(1),β=74.83(1),γ=88.21(1);Z=1:V=1.1191nm~3.配合物单元中钆为9配位,其配位多面体为三冠三角棱柱体;锰为6配位,形成八面体.     

稀土胺羧酸配合物的研究 I. {[MnGd(DTPA)(H2O)5]2·H2O}n配合物的合成和晶体结构

本文首次合成了{MnLn(DTPA)(H2O)5]·H2O}n异核链式配合物(Ln=Gd, Er, Y)单晶,测定了{[MnGd(DTPA)(H2O)5]2·H2O]n的单晶结构。     

NMR titration and molecular model MOPAC calculation of protonation processes of two MRI ligands

The protonation process of two DTPA bis(amide) derivatives,DTPA-BDMA and DTPA-BDEA,was studied by using 1H NMR titration and MOPAC calculation.Their protonation process was proposed in the order of the central amine,the terminal amines,the central carboxyl,the terminal carboxyl,the other terminal carboxyl and central amine.During the protonation of the terminal amine,there existed a large fraction of proton transfer from the central amine to the other terminal amine.     

具有荧光探针的靶向肽/聚(醚-酰胺)制备及其肝癌细胞靶向性能研究

通过端氨基聚乙二醇PEG(Ⅰ)与二亚乙基三胺五乙酸二酐(DTPAA)开环合成新型端氨基聚(醚-酰胺)(PEG/DTPA)共聚物造影剂配体(Ⅱ)(Step1);Ⅱ的端氨基与偶联剂3-马来酰亚胺苯甲酸-N-琥珀酰亚胺酯(MBS)的活化端COOH反应,生成偶联剂/聚(醚-酰胺)MB/PEG/DTPA(Ⅲ′)(Step2);再通过Ⅲ′中MBS的CC双键与肝癌细胞靶向黏附肽FAM-AGKGTPSLETTPC-(SH)-COOH(FAM-13)上的巯基SH发生Michael加成反应(Step3),合成含有荧光探针FAM(5-carboxyfluorescein)的肝癌靶向肽/聚(醚-酰胺)(FAM-13/PEG/DTPA,Ⅲ).用1H-NMR和13C-NMR等方法对共聚物进行表征.Ⅲ对正常肝细胞L-02几乎观察不到荧光现象,而对肝癌细胞BEL-7404则有很强的黄绿色荧光,Ⅲ对肝癌细胞有很强的靶向性.大分子配体Ⅲ可望用于制备大分子造影剂及靶向载体负载药物.     

二亚乙基三胺五乙酸修饰的固体汞合金电极测定铬(Ⅵ)和无机态铬(Ⅲ)

介绍了一种基于Cr(Ⅲ)-二亚乙基三胺五乙酸(DTPA)-NO3-体系的催化作用测定溶液中铬(Ⅵ)和无机态铬(Ⅲ)的方法.制作了银汞合金电极,并在其表面通过自组装修饰上DTPA.在含有0.1mol/L HAc-NaAc (pH=5.5)缓冲液和0.25mol/L KNO3溶液中,当电极电位在-0.80--1.40V间进行阴极化扫描时,溶液中Cr6 在电极表面被还原成为Cr3 并与电极表面上的DTPA络合,同时溶液中无机态铬(Ⅲ)也与DFPA络合,于-1.24V左右形成灵敏的还原峰.通过改变扫描前富集方式,分别实现铬(Ⅵ)和无机态铬(Ⅲ)的测定.铬(Ⅵ)和无机态铬(Ⅲ)的线性范围分别为:5.0×10-9～5.0×10-6mol/L和1.0×10-8～5.0× 10-6mol/L,检测限为1.6×10-10mol/L和5.1×10-9mol/L.对溶液进行11次平行测定相对标准偏差为4.3%.该法用于实际水样测定,Cr(Ⅵ)和Cr(Ⅲ)的标准加入回收率为98.5%～105.0%.     

螯合稀土金属标记蛋白质技术的建立与优化

建立了一种基于螯合稀土金属标记蛋白质的技术,优化了影响标记效率的各种条件.在50 mmol/L TEAB缓冲体系(pH 7.5),DTPA与肽段摩尔比为100: 1,常温反应30 min的条件下,DTPA标记完全;在100 mmol/L乙酸铵缓冲液(pH 6.0),稀土金属与DTPA摩尔比为4: 1,37 ℃反应1 h的条件下,稀土金属螯合反应完全.考察了不同稀土金属的螯合效率,发现离子半径最小的Lu螯合效率最高.本方法被成功应用于肽混合物标记.     

离子选择电极在络合滴定中的应用 Ⅱ、用 Cd~(2+)选择电极指示微量镅的滴定终点

我们曾用Cu~(2+)、Cd~(2+)选择电极指示微量钆的EDTA络合反滴定,结果较为满意。镅与钆的化学性质相似,可以用同样方法测定镅。根据我们过去的工作,在镅的络合滴定中选用DTPA(Diethylenetria-minepentaacetic acid,二乙撑三胺五乙酸)作络合剂比用EDTA好,所以本文选用DTPA,并使用Cd~(2+)作为DTPA的反滴定剂。本法操作简单、安全,工作人员所受放射性辐射剂量较目视络合滴定法为少。对于380微克镅的测定,准确度和精     

肝靶向性聚天冬酰胺磁共振成像造影剂

用吡哆胺(PM)作为肝靶向基团,先与DTPA双N-羟基琥珀酰亚胺活性酯(SuO-DTPA-OSu)反应生成含一个吡哆胺的DTPA单N-羟基琥珀酰亚胺活性酯(SuO-DTPA-PM),再分别与α,β-聚(2-羟乙基)-L-天冬酰胺和α,β-聚(2-胺乙基)-L-天冬酰胺反应,合成了2类肝靶向性大分子配体,并制备了它们的Gd(Ⅲ)配合物.对所合成的大分子配体以及钆配合物进行了表征.测试了配合物的弛豫率.初步测试大分子载体PHEA和PAEA及其钆配合物的细胞毒性.研究了大分子配体在小白鼠体内分布和大分子钆配合物对大白鼠肝脏造影成像性能.结果表明,与临床广泛应用的小分子磁共振成像造影剂Gd-DTPA相比,以上2类大分子造影剂的弛豫率有明显的提高,并且具有较好的肝靶向性和肝脏成像对比度及清晰度.     

新型生物质基复合水凝胶球珠高效吸附去除Ni-EDTA络合物的特性与机制

以壳聚糖(CS)与海藻酸钠(SA)为基体,以四乙烯三胺五乙酸(DTPA)与聚乙烯亚胺(PEI)为改性试剂,制备了富含氨基与羧基的新型生物质基复合水凝胶球珠MCS/SA@PEI,并系统深入研究其吸附去除Ni-EDTA络合物的特性与机制.FT-IR、XPS等表征结果均证明氨基与羧基被成功引入.该体系的最优化条件为:pH3,...     

The Preparation of Perovskite Nano Powder by Sol-gel from DTPA and the Mechanism of Thermal Decomposition

Dy0.8Sr0.2FeO3 nano powder, a synthetic oxide, is made by sol-gel method from metal nitrate and diethylenetriaminepentaaeetic acid (DTPA), and the processing parameters are optimized.The process of the preparation, thermal decomposition and the property of the powder are studied by TG-DTA, IR, TEM, and XRD. The diameter of the average grain is about 70 nm. This new technique can be used in the preparation and the studying of ha‘no materials in the complex oxide system.     

2-十四烷基-DTPA及其钆(Ⅲ)螯合物的合成与表征(英)

Synthesis and characterization of the ligand, [2-tetradecyl-3,6,9-tris(carboxymethyl)-3,6,9-triazaundecan-1,11-dioic acid, H₅L] and its Gd(Ⅲ) chelate are described. Protonation constants for H₅L (lgK_i^H = 10.80, 8.40, 4.30, 2.80, 2.15) and the stability constant for GdL^2- (lgK_GdL^2-= 22.75) were determined by potentiometric titration and are similar with the related values of DTPA and Gd-DTPA respectively. The results obtained show that the basicity of the ligand and the stability constant of its Gd(Ⅲ) chelate are not obviously altered after introduction of a linear chain tetradecyl group at the terminal acetic acid residue of DTPA.     

螯合剂对结合在人血清白蛋白(HSA)上的铜离子活动化能力的研究

用凝胶色谱法研究了螯合剂使结合在人血清白蛋白上的铜(Ⅱ)活动化的能力,若用在螯合剂存在时和无螯合剂存在时蛋白部分结合金属量之比作为表征活动化能力的参数,有如下顺序:Trien>DTPA>EDTA>EGTA>NTA>IDA除Trien和DTPA外,其他几种螯合剂的活动化能力的对数值与其相应的条件稳定常数的对数值之间有一线性关系.Trien和DTPA的反常被认为与复杂的反应历程有关,这可能涉及三元配合物的形成。     

螯合剂对结合在人血清白蛋白(HSA)上的铜离子活动化能力的研究

用凝胶色谱法研究了螯合剂使结合在人血清白蛋白上的铜(Ⅱ)活动化的能力,若用在螯合剂存在时和无螯合剂存在时蛋白部分结合金属量之比作为表征活动化能力的参数,有如下顺序:Trien>DTPA>EDTA>EGTA>NTA>IDA除Trien和DTPA外,其他几种螯合剂的活动化能力的对数值与其相应的条件稳定常数的对数值之间有一线性关系.Trien和DTPA的反常被认为与复杂的反应历程有关,这可能涉及三元配合物的形成.